In experimental mouse models of the Li-Fraumeni syndrome, TP53 mutations, different from the c.605G>A p.R202H TP53 mutation we identified, have been shown to increase the incidence of metastases [17]. Here, TP53 is linked to Li-Fraumeni syndrome.